A5019970806- Diabetes Management and Research
- Diabetes Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Metabolism, Diabetes, and Cancer
- Diet and metabolism studies
- Diabetes and associated disorders
- Pharmacology and Obesity Treatment
- Pancreatic function and diabetes
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Diet, Metabolism, and Disease
- Neurological Disorders and Treatments
- Lipoproteins and Cardiovascular Health
- Adipokines, Inflammation, and Metabolic Diseases
- Cardiovascular Function and Risk Factors
- Blood Pressure and Hypertension Studies
- Birth, Development, and Health
- Diabetes Management and Education
- Chronic Kidney Disease and Diabetes
- Adipose Tissue and Metabolism
- Natural Antidiabetic Agents Studies
- Nutritional Studies and Diet
- Liver Disease Diagnosis and Treatment
- Lipid metabolism and disorders
- Gestational Diabetes Research and Management
- Obesity, Physical Activity, Diet
Icahn School of Medicine at Mount Sinai
2016-2025
Mount Sinai Medical Center
1986-2023
Mount Sinai Hospital
2016-2022
American Diabetes Association
2021
Ruijin Hospital
2018
Diabetes Australia
2015-2017
New York Proton Center
2003-2017
Mount Sinai Hospital
1988-2017
Regione Lazio
2016
Mount Sinai Hospital
2015-2016
We randomized 749 insulin-treated patients on the rolls of Mount Sinai Medical Center Diabetes Clinic in a controlled trial diabetic patient education; 345 agreed to participate, whom 165 were assigned education group and 180 control group. Cognitive scores increased from 5.3 ± 1.6 5.8 group, but there was no change whose score 1.7 before after intervention (P = .0073). HbA1c fell 6.8 2.1 6.1 2.0% 6.6 2.0 6.3 an insignificant difference . 1995). The fasting blood glucose decreased 223 94 179...